CDMRP Neurofibromatosis Research Program: Neurofibromatosis Research Academy - Scholar Award

This award mechanism enables the Scholar to pursue a neurofibromatosis project that may be basic, translational, and/or clinical research, and addresses at least one of the FY23 NFRP Areas of Emphasis under the guidance of a Career Guide. The PI must be an early-career researcher or physician-scientist within 10years of completion of their terminal degree by the time of the application deadline. 

Areas of Emphasis:

• NF2- and schwannomatosis-related areas (e.g., hearing, balance, schwannoma, ependymoma, meningioma, LZTR1, SMARCB1).
• Endpoint validation, biomarker discovery, and technological innovation for assessments
• Application of data science.
• Non-tumor manifestations
• Heterogeneity of NF-related phenotypes.
• Genetics, genomics, epigenetics, systems biology, metabolomics or similar approaches.
• Preclinical efficacy studies.
• Target identification and drug discovery.
• Nutritional, environmental, and other modifiers of NF.
• Health services research

It is expected that 3 awards will be granted. 

Funding: $1,200,000 total
Duration: 4 years

Research Authority due date: 1.9.26

Pre application (required)  due date: 8.9.26
Full proposal due date: 22.9.26